drugset / Trial / NCT02915809

A Study to Evaluate Efficacy and Safety of GC3110B in Healthy Adults

NCT02915809 ↗

Phase 3 Unknown 414 enrolled Green Cross Corporation
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to evaluate immunological efficacy and safety of GC3110B versus GCFLU Quadrivalent Inj. among healthy adults in 18 to 60 years of age.

Timeline

Start
2016-10
Primary completion
2016-12
Completion
2017-05

Drugs

EvaluationDrugModalityDoseRoute
Subject GC3110B Vaccine 0.5 ml Intramuscular
Comparator GCFLU Quadrivalent Inj. Vaccine 0.5 ml Intramuscular

Indications